Novartis (NVS) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$56.7B

Revenue (quarter)

$15.0B

Revenue growth (year over year)

+0.78%

Gross profit (trailing twelve months)

$42.4B

Gross margin

74.74%

Net income (trailing twelve months)

$12.7B

Net income (quarter)

$3.3B

Net income growth (year over year)

−19.06%

Net margin

22.48%

Return on equity

30.55%

EPS (trailing twelve months)

$6.67

Book value per share

$21.86

P/E (trailing twelve months)

22.71

Price to book

6.91

Debt to assets

65.63%

Payout ratio

54.65%

Dividend yield

2.04%

• Is Novartis (NVS) profitable?

  Yes. Novartis earned $12.7B in net income over the trailing twelve months, a net margin of 22.48%.

• How much revenue does Novartis (NVS) make?

  Novartis generated $56.7B in revenue over the trailing twelve months, up 0.78% year over year.

• What is NVS's P/E ratio?

  Novartis trades at 22.7 times trailing twelve-month earnings, on an EPS of $6.67.

• How do I buy stock in Novartis (NVS)?

  NVS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.